New #postdoc / senior researcher position in our team at Turku #Metabolomics Centre, in #massspectrometry #imaging. Deadline December 17.
#MSimaging #lipidomics #proteomics
ats.talentadore.com/apply/erikoi...
@rafagarrett
Prof. of Chemistry @UFRJ-Brazil, currently working at Boston Children’s Hospital-Harvard Medical School. Interested in clinical metabolomics and rare diseases. https://www.ladetec.iq.ufrj.br/labmeta/; http://www.researcherid.com/rid/G-6949-2012
New #postdoc / senior researcher position in our team at Turku #Metabolomics Centre, in #massspectrometry #imaging. Deadline December 17.
#MSimaging #lipidomics #proteomics
ats.talentadore.com/apply/erikoi...
I can see that :)
Researchers in low & middle-income countries face major challenges when conducting #omics research. What hurdles do we need to overcome? How do we do it? How do we make research fair and equitable?
See our latest paper in Nature Biotechnology to understand these barriers and enablers: rdcu.be/dK4Hb
Here is a second bleetorial about a paper we recently preprinted. Here @shipei-xing.bsky.social wanted to find a solution to be able to re-use data in the public domain with MS1 data only - LC-MS and imaging mass spectrometry data. www.biorxiv.org/content/10.1...
Enjoying this deep dive into the link between coffee and the microbiome
They found a microbe (Lawsonibacter asaccharolyticus) that is 4- to 8-fold more abundant in coffee drinkers, and correlates with coffee intake in worldwide populations
www.nature.com/articles/s41...
Hi David. Please add me!